The cost of schizophrenia in Japan

Sado, Mitsuhiro, Inagaki, Ataru, Koreki, Akihiro, Knapp, Martin R.J. ORCID: 0000-0003-1427-0215, Kissane, Lee Andrew, Mimura, Masaru and Yoshimura, Kimio (2013) The cost of schizophrenia in Japan. Neuropsychiatric Disease and Treatment, 9. pp. 787-798. ISSN 1176-6328

Preview

PDF - Published Version Download (552kB) | Preview

Abstract

Schizophrenia is a disorder that produces considerable burdens due to its often relapsing/remitting or chronic longitudinal course. This burden is felt not only by patients themselves, but also by their families and health care systems. Although the societal burden caused by this disorder has been evaluated in several countries, the magnitude of the societal cost of schizophrenia in Japan has never been estimated. The aim of this study is to clarify the societal burden of schizophrenia by estimating the cost of schizophrenia in Japan in 2008. Methods: A human capital approach was adopted to estimate the cost of schizophrenia. The total cost of schizophrenia was calculated as the sum of the direct, morbidity, and mortality costs. Schizophrenia was defined as disorders coded as F20.0-F20.9 according to the International Classification of Diseases-10. The data required to estimate the total cost was collected from publicly available statistics or previously reported studies. Results: The total cost of schizophrenia in Japan in 2008 was JPY 2.77 trillion (USD 23.8 billion). While the direct cost was JPY 0.770 trillion (USD 6.59 billion), the morbidity and mortality costs were JPY 1.85 trillion (USD 15.8 billion) and JPY 0.155 trillion (USD 1.33 billion), respectively. Conclusion: The societal burden caused by schizophrenia is tremendous in Japan, similar to that in other developed countries where published data exist. Compared with other disorders, such as depression or anxiety disorders, the direct cost accounted for a relatively high proportion of the total cost. Furthermore, absolute costs arising from unemployment were larger, while the prevalence rate was smaller, than the corresponding results for depression or anxiety in Japan.

Item Type:	Article
Official URL:	http://www.dovepress.com/neuropsychiatric-disease-...
Additional Information:	© 2013 Sado et al, publisher and licensee Dove Medical Press Ltd.
Divisions:	LSE
Subjects:	H Social Sciences > HV Social pathology. Social and public welfare. Criminology
Date Deposited:	19 Jun 2013 14:28
Last Modified:	20 Nov 2024 22:57
Projects:	(H22-SHOGAI-36)
Funders:	Ministry of Health, Labour and Welfare of Japan
URI:	http://eprints.lse.ac.uk/id/eprint/50809

Actions (login required)

View Item